Publication: Advanced Glycation End Products and Their Involvement in Cardiovascular Disease.
Loading...
Identifiers
Date
2020-04-03
Authors
Yubero-Serrano, Elena M
Perez-Martinez, Pablo
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications
Abstract
Circulating levels and tissue accumulation of advanced glyca-tion end products (AGEs) are strongly linked with metabolicimbalance and the progression of chronic diseases, includingcardiovascular disease (CVD). 1,2 Diet is the most importantexogenous source of AGEs contributing to the total body AGEsload. Experimental and clinical evidence suggests that thereduction in body AGE content, by dietary AGE restriction,could modulate different pathways involved in the pathophy-siology of CVD
Description
MeSH Terms
Cardiovascular diseases
Diet
Diet, healthy
Diet, mediterranean
Glycation end products, advanced
Humans
Protective factors
Receptor for advanced glycation end products
Risk assessment
Risk factors
Risk reduction behavior
Signal transduction
Diet
Diet, healthy
Diet, mediterranean
Glycation end products, advanced
Humans
Protective factors
Receptor for advanced glycation end products
Risk assessment
Risk factors
Risk reduction behavior
Signal transduction
DeCS Terms
Conducta de reducción del riesgo
Dieta mediterránea
Enfermedades cardiovasculares
Medición de riesgo
Productos finales de glicación avanzada
Receptor para productos finales de glicación avanzada
Transducción de señal
Dieta mediterránea
Enfermedades cardiovasculares
Medición de riesgo
Productos finales de glicación avanzada
Receptor para productos finales de glicación avanzada
Transducción de señal
CIE Terms
Keywords
Advanced glycation end products, Cardiovascular diseases, Diet
Citation
Yubero-Serrano EM, Pérez-Martínez P. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Angiology. 2020 Sep;71(8):698-700